CALABRETTA, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.054
AS - Asia 12.207
EU - Europa 10.104
SA - Sud America 2.007
AF - Africa 227
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 19
Totale 51.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.692
GB - Regno Unito 4.101
CN - Cina 3.645
SG - Singapore 3.141
HK - Hong Kong 1.727
BR - Brasile 1.577
VN - Vietnam 1.361
IT - Italia 1.204
SE - Svezia 1.062
DE - Germania 839
UA - Ucraina 698
FI - Finlandia 685
BD - Bangladesh 583
TR - Turchia 454
RU - Federazione Russa 452
FR - Francia 375
KR - Corea 336
BG - Bulgaria 267
IN - India 211
CA - Canada 175
AR - Argentina 161
ID - Indonesia 152
MX - Messico 103
JP - Giappone 101
IQ - Iraq 76
EC - Ecuador 72
NL - Olanda 61
ZA - Sudafrica 58
CO - Colombia 51
PL - Polonia 51
PK - Pakistan 49
VE - Venezuela 47
AT - Austria 44
MA - Marocco 44
AE - Emirati Arabi Uniti 41
IE - Irlanda 41
MY - Malesia 38
BE - Belgio 36
UZ - Uzbekistan 34
PH - Filippine 33
ES - Italia 32
SA - Arabia Saudita 30
EG - Egitto 28
EU - Europa 25
CL - Cile 24
DZ - Algeria 23
LT - Lituania 23
TN - Tunisia 22
AZ - Azerbaigian 21
PE - Perù 21
UY - Uruguay 21
PY - Paraguay 20
CZ - Repubblica Ceca 19
JO - Giordania 19
NP - Nepal 19
PT - Portogallo 19
IR - Iran 17
AU - Australia 14
CR - Costa Rica 14
KE - Kenya 14
KZ - Kazakistan 13
TH - Thailandia 13
OM - Oman 12
CH - Svizzera 11
DO - Repubblica Dominicana 10
PS - Palestinian Territory 10
QA - Qatar 10
BO - Bolivia 9
LB - Libano 9
LV - Lettonia 9
RO - Romania 9
BY - Bielorussia 8
GT - Guatemala 8
JM - Giamaica 8
KG - Kirghizistan 8
HN - Honduras 7
PA - Panama 7
TW - Taiwan 7
AL - Albania 6
ET - Etiopia 6
HU - Ungheria 6
RS - Serbia 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
AO - Angola 5
GE - Georgia 5
GR - Grecia 5
IL - Israele 5
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CY - Cipro 4
DK - Danimarca 4
EE - Estonia 4
HR - Croazia 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
Totale 51.576
Salva come PNG Salva come JPEG
Città #
Southend 3.067
Fairfield 2.811
Ashburn 2.395
Woodbridge 2.276
Santa Clara 2.053
Singapore 1.953
Hong Kong 1.716
Houston 1.626
Jacksonville 1.543
Hefei 1.303
Ann Arbor 1.133
Chandler 1.095
Seattle 1.011
Cambridge 1.007
Wilmington 1.007
Dearborn 902
Nyköping 746
San Jose 685
London 619
Beijing 590
Ho Chi Minh City 476
The Dalles 426
Helsinki 423
Modena 423
Council Bluffs 357
Los Angeles 356
San Diego 335
Hanoi 326
Seoul 326
New York 283
Princeton 270
Sofia 262
Eugene 250
Chicago 219
Izmir 210
Lauterbourg 208
Buffalo 178
Milan 173
Shanghai 134
São Paulo 132
Columbus 127
Des Moines 125
Moscow 113
Redwood City 102
Jakarta 93
Dallas 87
Falls Church 82
Munich 80
Salt Lake City 79
Da Nang 77
Tokyo 70
Falkenstein 69
Haiphong 58
Boardman 57
Frankfurt am Main 57
Toronto 56
Norwalk 52
Guangzhou 50
Orem 49
Rome 43
Nanjing 42
Dublin 40
Phoenix 40
Warsaw 40
Miano 39
Rio de Janeiro 38
Mexico City 37
Belo Horizonte 35
Brasília 35
Denver 35
Philadelphia 35
Atlanta 34
Brussels 34
Kent 34
Nuremberg 34
Chennai 33
Tampa 33
Elk Grove Village 32
Baghdad 31
Johannesburg 30
Curitiba 29
Quito 29
Tashkent 29
Brooklyn 28
Bremen 27
Hounslow 26
Biên Hòa 25
Montreal 25
Dongguan 24
Kilburn 24
Kunming 24
Verona 24
Zhengzhou 24
Hải Dương 23
Porto Alegre 23
Turku 23
Wuhan 23
Amsterdam 22
Brantford 22
Guayaquil 22
Totale 38.038
Salva come PNG Salva come JPEG
Nome #
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients 447
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 416
Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants 384
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 377
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 373
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 368
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 362
Effects of C/EBP alpha and C/EBP beta in BCR/ABL-expressing cells - Differences and similarities 359
BCR/ABL activates mdm2 rnRNA translation via the La antigen 342
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis 334
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells 334
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BICRABL-expressing cells 329
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells 325
Altered expression of G1 specific genes in human malignant myeloid cells. 320
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells viatranscriptional repression of STAT 5 and Mcl-1 320
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis 320
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. 317
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 312
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 311
The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform. 307
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells 305
Suppression of autophagy by BCR/ABL 302
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 294
CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia 292
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 291
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk 289
The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation 286
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells 286
Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin 286
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients 285
Activation of human B-MYB by cyclins. 283
BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway 281
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 276
Physical interaction between CDK9 and B-MYB results in suppression of B-MYB gene autoregulation. 272
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. 272
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 270
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis 270
Cell-cycle-dependent expression of human ornithine decarboxylase. 266
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects 263
Coding sequence and growth regulation of the human vimentin gene. 263
Positive autoregulation of c-myb expression via myb binding sites in the 5' flanking region of the human c-myb gene 262
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. 262
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells 262
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 259
Regulation of Balb/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. 256
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells 256
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 256
Altered mRNA translation: possible mechanism for CML disease progression. 256
Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects 255
The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. 255
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα 254
Regulation of microRNA-145 by growth arrest and differentiation. 254
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. 252
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo 251
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide 251
The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. 251
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. 250
B-myb alters the response to myeloid precurson cells to G-CSF 249
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. 249
Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. 245
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. 245
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 245
Targeting CDK6 and BCL2 exploits the "MYB addiction" of Phþ acute lymphoblastic leukemia 245
Antisense oligonucleotides. 244
Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. 241
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? 241
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. 240
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. 239
BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2 238
Ricerca di markers diagnostici, prognostici e predittivi in carcinomi mammari attraverso analisi proteomica 238
Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. 235
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction 234
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 233
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells 232
Expression of the Transcriptional Repressor Gfi-1 Is Regulated by C/EBP{alpha} and Is Involved in Its Proliferation and Colony Formation-Inhibitory Effects in p210BCR/ABL-Expressing Cells. 232
B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. 232
Guidelines for the use and interpretation of assays for monitoring autophagy. 231
Direct transactivation of the anti-apoptotic gene Apolipoprotein J (Clusterin) by B-MYB. 229
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model 229
Role of p53 in hematopoietic recovery after cytotoxic treatment. 229
Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene 229
Leukemia stem cells: Old concepts and new perspectives 229
Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia 228
Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition 228
Granulocytic differentiation of normal hematopoietic precursor cells induced by transcriptional factor PU.1 correlates with negative regulation of the c-myb promoter. 226
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant 226
Translational regulation by the p210 BCR/ABL oncoprotein 225
TGF-β-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. 224
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 224
Structural and functional analysis of a growth-regulated gene, the human calcyclin 224
A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. 223
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. 222
miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. 222
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 222
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. 221
Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. 219
Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells 218
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 217
Expression of c-myc and induction of DNA synthesis by platelet-poor plasma in human diploid fibroblasts. 217
B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells 216
Totale 26.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 0 0 0 0 0 0 185
2021/20224.087 85 611 409 248 127 197 274 218 439 272 738 469
2022/20233.287 442 373 245 304 355 528 79 318 416 36 112 79
2023/20241.946 82 126 134 158 502 183 274 187 43 19 53 185
2024/20257.583 210 29 56 482 1.454 1.048 754 441 808 280 838 1.183
2025/202615.924 965 885 1.720 2.086 1.512 1.093 1.876 949 1.336 1.329 1.201 972
Totale 51.728